RxDoctor Payments Data

David Farmer, PA

Medical · Stockbridge, GANPI 1619985041

Payments from drug & device makers

$6,209in general payments, 2019–2025

Across 392 payments — averaging $15.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$783
  • AbbVie$767
  • Novo Nordisk$560
  • Amgen$379
  • AstraZeneca$355
  • Corium, LLC$329
  • plus $3K from 39 others

What the payments were for

  • Food & beverage$6,209100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,209 in reported general payments places this provider in the 85th percentile of 950 medical providers in Georgia.

See all medical providers in Georgia

Medicare billing

Part B allowed, 2024
$20,408
Medicare patients
97
Services billed
346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide103$108,113
JardianceEmpagliflozin93$72,048
Trelegy ElliptaFluticasone/Umeclidin/Vilanter76$55,939
FarxigaDapagliflozin Propanediol39$38,106
JanuviaSitagliptin Phosphate25$26,057
EliquisApixaban27$25,658
RybelsusSemaglutide17$23,801
TrulicityDulaglutide20$18,770
Tresiba Flextouch U-200Insulin Degludec17$15,291
LinzessLinaclotide16$9,803
Tresiba Flextouch U-100Insulin Degludec15$6,627
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$6,045
BrilintaTicagrelor12$5,204
Albuterol Sulfate HfaAlbuterol Sulfate148$3,215
Gabapentin113$1,537

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$560$131,914120 claims
Boehringer IngelheimJardiance$178$72,04893 claims
GSKTrelegy Ellipta, Anoro Ellipta$89$61,98489 claims
AstraZenecaFarxiga, Brilinta$355$43,31051 claims
MerckJanuvia$64$26,05725 claims
PfizerEliquis$203$25,65827 claims
Lilly USA, LLCTrulicity$783$18,77020 claims
AbbVieLinzess$767$9,80316 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$11$777105 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 950 medical providers in Georgia.

Other medical in Stockbridge

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →